Series B funding round for Arrakis Therapeutics raising $75M in April 2019
Series B funding round for Arrakis Therapeutics raising $75M in April 2019
| Investor | Firm Type | Partner |
|---|
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Private | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Public | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$113M
Top Valuation
-
Arrakis Therapeutics raised $75M in a Series B round.
The round was announced on 04/01/19.
The round was led by Jakob Loven.